Douglas Nachand

Appearances

ONE YEAR FOLLOW UP IN THREE PHASE IB/IIA CLINCIAL TRIALS OF EX VIVO EXPANDED ALLOGENEIC BONE MARROW DERIVED MESENCHYMAL STEM CELLS FOR THE TREATMENT OF FISTULIZING CROHN'S DISEASE
Date
May 7, 2023
Sentinel node navigated surgery (SNNS) might offer a less invasive alternative to esophagectomy to tailor the extent of lymphadenectomy in patients with high-risk T1 esophageal adenocarcinoma (EAC)…
Presenter
Amy L. Lightner
Mayo Clinic
Speakers
Ana Otero Pineiro
Jane Reese
Justin Ream
Douglas Nachand
Ashley Adams
Alexandra VanDenBossche
Neda Dadgar
Tracy Hull